Andrew R. Blight
2012
In 2012, Andrew R. Blight earned a total compensation of $1.5M as Chief Scientific Officer at Acorda Therapeutics, a 2% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $172,430 |
|---|---|
| Option Awards | $585,372 |
| Salary | $404,467 |
| Stock Awards | $363,630 |
| Other | $7,350 |
| Total | $1,533,249 |
Blight received $585.4K in option awards, accounting for 38% of the total pay in 2012.
Blight also received $172.4K in non-equity incentive plan, $404.5K in salary, $363.6K in stock awards and $7.4K in other compensation.
Rankings
In 2012, Andrew R. Blight's compensation ranked 4,494th out of 11,487 executives tracked by ExecPay. In other words, Blight earned more than 60.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,494 out of 11,487 | 61st |
Division Manufacturing | 1,557 out of 4,253 | 63rd |
Major group Chemicals And Allied Products | 357 out of 1,198 | 70th |
Industry group Drugs | 221 out of 920 | 76th |
Industry Biological Products, Except Diagnostic Substances | 39 out of 160 | 76th |
Source: SEC filing on April 25, 2014.
Blight's colleagues
We found four more compensation records of executives who worked with Andrew R. Blight at Acorda Therapeutics in 2012.